HSP70, known for its protective effects, including inhibition of transforming growth factor-beta-β (TGF-β)-dependent epithelial-mesenchymal transition and anti-inflammatory properties [34], may delay IPF progression. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.